These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3213151)

  • 21. Changes in kidney function following heart failure treatment: focus on renin-angiotensin system blockade.
    Blankstein R; Bakris GL
    Heart Fail Clin; 2008 Oct; 4(4):425-38. PubMed ID: 18760754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Kidney insufficiency and persistent hypotension following compromise of the renin-angiotensin system in a fetus and a young infant].
    van Lieburg AF; Monnens LA
    Ned Tijdschr Geneeskd; 2001 Apr; 145(14):695-8. PubMed ID: 11530709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Renal function after administration of angiotensin-converting enzyme inhibitors].
    Waeber B; Burnier M; Nussberger J; Brunner HR
    Schweiz Med Wochenschr; 1987 Sep; 117(37):1359-62. PubMed ID: 3672075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlation of renin-angiotensin system and prostanoids system in renal circulation: dissociation of renal blood flow and glomerular filtration rate in acute alterations of renal blood pressure].
    Goto F
    Masui; 1984 Nov; 33(11):1204-12. PubMed ID: 6394780
    [No Abstract]   [Full Text] [Related]  

  • 25. [Renal side effects of angiotensin converting enzyme inhibitors].
    Schmidt A; Mayer G
    Wien Med Wochenschr; 1996; 146(16):454-6. PubMed ID: 9036683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contrasting effects of the renin-angiotensin system on renal function disclosed during converting enzyme inhibition in patients with renal hypertension.
    Rasmussen S; Ibsen H; Giese J
    Scand J Urol Nephrol Suppl; 1984; 79():49-52. PubMed ID: 6089319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal response to pentobarbital anesthesia in rats: effect of interrupting the renin-angiotensin system.
    Walker LA; Gellai M; Valtin H
    J Pharmacol Exp Ther; 1986 Mar; 236(3):721-8. PubMed ID: 3512818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure].
    Schunkert H; Holmer SR; Riegger G
    Z Kardiol; 1993; 82 Suppl 4():1-6. PubMed ID: 8147057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neurohormonal assessment in heart failure: from the sophisticated laboratory to practical indications].
    Dei Cas L; Metra M; Visioli O
    G Ital Cardiol; 1993 Feb; 23(2):193-204. PubMed ID: 8098306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials?
    Sambhi MP; Gavras H; Robertson JI; Smith WM
    West J Med; 1993 Mar; 158(3):286-94. PubMed ID: 8460511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of drugs acting on the natriuretic system and the renin-angiotensin system in heart failure.
    Chee KH; Amudha K; Hussain NA; Haizal HK; Choy AM; Lang CC
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):140-8. PubMed ID: 14608517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High renin in heart failure: a manifestation of hyponatremia.
    Levine TB; Cohn JN; Vrobel T; Franciosa JA
    Trans Assoc Am Physicians; 1979; 92():203-7. PubMed ID: 398618
    [No Abstract]   [Full Text] [Related]  

  • 35. Renal and adrenal responses to hypoxemia during angiotensin-converting enzyme inhibition in lambs.
    Weismann DN; Herrig JE; McWeeny OJ; Ayres NA; Robillard JE
    Circ Res; 1983 Feb; 52(2):179-87. PubMed ID: 6297830
    [No Abstract]   [Full Text] [Related]  

  • 36. Refractory vasodilation after cardiopulmonary bypass for heart transplantation in recipients on combined amiodarone and angiotensin-converting enzyme inhibitor therapy: a role for vasopressin administration.
    Mets B; Michler RE; Delphin ED; Oz MC; Landry DW
    J Cardiothorac Vasc Anesth; 1998 Jun; 12(3):326-9. PubMed ID: 9636919
    [No Abstract]   [Full Text] [Related]  

  • 37. Indomethacin induced hypotension in sodium and volume depleted rats.
    Stahl R; Dienemann H; Kneissler U; Christ H; Helmchen U
    Klin Wochenschr; 1979 Feb; 57(3):143-5. PubMed ID: 439781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comments on the letter on hyponatremia associated with diuretic use and urinary retention in an older man.
    Rosenbaum RW; Ensberg M
    J Am Geriatr Soc; 2010 Dec; 58(12):2445-6; author reply 2446-7. PubMed ID: 21143458
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyponatremia after initiation of angiotensin-converting enzyme inhibitor in a geriatric patient with chronic heart failure: A case of mineralocorticoid-responsive hyponatremia of the elderly.
    Iwagaki H; Haruki N; Junichi N; Tamura M; Otsuji Y
    Geriatr Gerontol Int; 2017 May; 17(5):847-848. PubMed ID: 28508500
    [No Abstract]   [Full Text] [Related]  

  • 40. Letter: Hypotensive effect of angiotensin-converting-enzyme inhibitor SQ 20,881.
    Gavras H; Brunner HR; Gavras I; Laragh JH
    Lancet; 1974 Aug; 2(7876):353. PubMed ID: 4136088
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.